136 related articles for article (PubMed ID: 16803524)
1. Analysis of the in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells.
Yim EK; Lee SB; Lee KH; Kim CJ; Park JS
Int J Gynecol Cancer; 2006; 16(3):1321-9. PubMed ID: 16803524
[TBL] [Abstract][Full Text] [Related]
2. Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines.
Yi JL; Shi S; Shen YL; Wang L; Chen HY; Zhu J; Ding Y
Int J Clin Exp Pathol; 2015; 8(2):1116-27. PubMed ID: 25972998
[TBL] [Abstract][Full Text] [Related]
3. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
4. Chan-Yu-Bao-Yuan-Tang and 5-fluorouracil synergistically induce apoptosis by means of the caspase-3 signaling pathway in lung and cervical cancer cells.
Zeng F; Liu X; Li Y; Chen G; Wang Y; Zhou S; Zhu W; Huang Y; Zhou J; Li S; Zhang Y
Mol Med Rep; 2011; 4(1):113-20. PubMed ID: 21461573
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of antiproliferative effects by treatment of 5-fluorouracil in cervical cancer cells.
Yim EK; Lee KH; Bae JS; Namkoong SE; Um SJ; Park JS
DNA Cell Biol; 2004 Nov; 23(11):769-76. PubMed ID: 15585135
[TBL] [Abstract][Full Text] [Related]
6. ERCC1 expression and chemosensitivity in uterine cervical adenocarcinoma cells.
Torii Y; Kato R; Minami Y; Hasegawa K; Fujii T; Udagawa Y
Anticancer Res; 2014 Jan; 34(1):107-15. PubMed ID: 24403450
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro.
Chung WH; Sung BH; Kim SS; Rhim H; Kuh HJ
Int J Oncol; 2009 Jun; 34(6):1669-79. PubMed ID: 19424586
[TBL] [Abstract][Full Text] [Related]
10. Chemoimmunosensitization of the T24 human bladder cancer line to Fas-mediated cytotoxicity and apoptosis by cisplatin and 5-fluorouracil.
Mizutani Y; Wu XX; Yoshida O; Shirasaka T; Bonavida B
Oncol Rep; 1999; 6(5):979-82. PubMed ID: 10425290
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anticancer activity of Thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells.
González-Sánchez I; Lira-Rocha A; Navarrete A; Loza-Mejía MA; Coronel-Cruz C; Mendoza-Rodríguez CA; Cerbón MA
Anticancer Res; 2012 Dec; 32(12):5159-65. PubMed ID: 23225412
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of cisplatin and 5-fluorouracil with irradiation on tumor cells in vitro.
Nagy B; Mucsi I; Molnár J; Thurzo L
Anticancer Res; 2002; 22(1A):135-8. PubMed ID: 12017276
[TBL] [Abstract][Full Text] [Related]
13. Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-kappaB independent pathway.
Takizawa K; Kamijo R; Ito D; Hatori M; Sumitani K; Nagumo M
Br J Cancer; 1999 Jun; 80(7):954-63. PubMed ID: 10362102
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor activity of irofulven in combination with 5-fluorouracil and cisplatin in human colon and ovarian carcinoma cells.
Poindessous V; Koeppel F; Raymond E; Cvitkovic E; Waters SJ; Larsen AK
Int J Oncol; 2003 Nov; 23(5):1347-55. PubMed ID: 14532976
[TBL] [Abstract][Full Text] [Related]
15. Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells.
Yim EK; Lee KH; Kim CJ; Park JS
Int J Gynecol Cancer; 2006; 16(2):690-7. PubMed ID: 16681749
[TBL] [Abstract][Full Text] [Related]
16. In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: timing of cisplatin treatment.
Cho H; Imada T; Oshima T; Shiozawa M; Rino Y; Takanashi Y
Gastric Cancer; 2002; 5(1):43-6. PubMed ID: 12021859
[TBL] [Abstract][Full Text] [Related]
17. Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells.
Liu Y; Wang X; Wang Y; Zhang Y; Zheng K; Yan H; Zhang L; Chen W; Wang X; Liu Q; Wang S; Wang Y
Int J Oncol; 2015 Jan; 46(1):299-307. PubMed ID: 25333998
[TBL] [Abstract][Full Text] [Related]
18. Treatment schedule-dependent effect of 5-fluorouracil and platinum derivatives in colorectal cancer cells.
Takara K; Fujita M; Minegaki T; Yamamoto K; Takahashi M; Yokoyama T; Okumura K
Eur J Pharm Sci; 2012 Feb; 45(3):272-81. PubMed ID: 22155546
[TBL] [Abstract][Full Text] [Related]
19. Melatonin sensitizes human cervical cancer HeLa cells to cisplatin-induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentation.
Pariente R; Pariente JA; Rodríguez AB; Espino J
J Pineal Res; 2016 Jan; 60(1):55-64. PubMed ID: 26462739
[TBL] [Abstract][Full Text] [Related]
20. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.
Jacobs C; Lyman G; Velez-García E; Sridhar KS; Knight W; Hochster H; Goodnough LT; Mortimer JE; Einhorn LH; Schacter L
J Clin Oncol; 1992 Feb; 10(2):257-63. PubMed ID: 1732427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
